Drug designations, product launches & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

Advertisement

IntegraGen’s miRpredX 31-3p test was awarded a CE mark for use in the European Union.

The FDA awarded Innovate Biopharmaceuticals’ INN-108 orphan drug designation.

CapsoVision launched its CapsoCloud, an exam management system.

Chemistry World reported on Takeda’s vision for the future; it involves a move away from generics and over-the-counter businesses into pharmaceutical research and development.

More articles on gastroenterology: 
GI center to know: Lakeside Endoscopy Center
PPIs included on list of drugs to ‘seriously consider deprescribing’
GI leader to know: Dr. Douglas Brouillette of Midwest Gastrointestinal Associates

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.